The Endocrine Society is advocating for you. In 2023 we achieved several important advocacy accomplishments, including: All these accomplishments were achieved because our members participated in our advocacy activities, online campaigns, Hill Days, and meetings with policymakers. Below are some examples of our advocacy victories. Advocacy to Lower the Cost of Insulin – The Endocrine Society...
Endocrine Society Recommends Bipartisan Solutions to Senate HELP Hearing on Diabetes, Obesity
The Endocrine Society commends the Senate Health, Education, Labor, and Pensions (HELP) Committee for calling attention to the issues that are fueling the diabetes epidemic in its December 14’s hearing and urges the Committee to support bipartisan legislation to begin to address the crisis in our country. More than 38 million Americans have diabetes, and...
Government Shutdown Averted for Second Time as Society Advocates to Fund Health, Research Programs With the clock running out on a federal government shutdown that was to begin midnight November 17, Congress passed a short-term bill to keep the government open. The bill will fund most health programs, including the National Institutes of Health (NIH),...
Endocrine Society Recommendations Incorporated in Draft UN Plastics Treaty
On September 6, the United Nations Environment Programme (UNEP) Secretariat released the initial “zero” draft of a treaty to address plastic pollution. The zero draft is a starting point for more detailed negotiations that will resume this month at the third session of the Intergovernmental Negotiating Committee (INC3) to develop an international legally binding instrument...
Endocrine Society Continues to Advocate for Insulin Affordability
The Endocrine Society continues to advocate for insulin affordability. Although new legislation to make insulin more affordable has been stalled in Congress, the Centers for Medicare and Medicaid Services (CMS) continues to advance a program to implement drug price negotiations to lower the cost of certain prescription drugs, including several diabetes medications. CMS recently hosted...
Four Diabetes Drugs Included in Medicare Price Negotiation List
In September, the federal government unveiled a list of the first 10 drugs that will undergo price negotiations between Medicare and pharmaceutical companies. Notably, four of these drugs are diabetes medications. New prices for these medicines will be announced in September 2024 and new prices will take effect on January 1, 2026, unless pharmaceutical companies...
Society Hosts Congressional Briefing on Anti-Obesity Medications as TROA Moves Forward in the House
The Endocrine Society hosted a congressional briefing in September to educate members of Congress and congressional staff on anti-obesity medications. The briefing featured two Endocrine Society members who are experts in obesity medicine. Jonathan Purnell, MD, professor of medicine at Oregon Health & Science University, provided attendees with an opportunity to learn more about these...
On Thursday September 14, Endocrine Society members joined hundreds of researchers, physicians, and patients on Capitol Hill as part of the 11th Annual Rally for Medical Research. Rally participants shared the same messages: ensuring the highest possible appropriation increase for the National Institutes of Health (NIH) in FY 2024 and completing the work on FY...
Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
